Deep 6 AI Inc. designs and develops software solutions that analyze clinical data to accelerate medical research and patient recruitment.
Subscribe to see Deep 6 AI Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Deep 6 AI Inc. is a healthtech company headquartered in United States. It has raised at least $47.1M across the 4 funding rounds on record. Its most recent funding round raised $26.9M in April 2022. Xcout tracks 1 named person at Deep 6 AI Inc., including Wout Brusselaers (CEO).
At least $47.1M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $26.9M | — | |
| SEC Form D filing | $17.3M | — | |
| SEC Form D filing | $5.9M | — | |
| Seed | $120,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Deep 6 AI Inc.'s closest competitors — see the full list of competitors and alternatives →
CloudMedx Inc. builds a clinical AI platform utilizing healthcare-specific natural language processing and machine learning technologies.
Triomics, Inc. is a U.S. healthcare technology company that uses artificial intelligence and natural-language processing to structure oncology data from clinical records and genomic reports. Its platform serves cancer centers, oncologists, and life-sciences organizations by supporting precision-oncology workflows such as clinical-trial matching and patient identification.
BEKHealth Corp is a privately held company founded in 2019 and headquartered in Branford, Connecticut, offering a suite of technology solutions designed to address critical needs in today's drug development and clinical trial environment.
Saama Technologies, Inc. provides AI-driven clinical analytics solutions for the life sciences and healthcare industries.
Diffusion Health is a health-technology company that utilizes artificial intelligence to operate as a clinical research site network, enabling healthcare practices to conduct clinical trials. The company aims to expand patient access to medical research.
CellaraRx is a healthtech company headquartered in Toronto, Ontario, that builds next-generation artificial intelligence platforms to help clinicians and drug developers improve cancer clinical trial patient selection.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Deep 6 AI Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.